Chadburn, Amy

Publications

Sort by

Co-Author Network

selected publications

Building the Model. Archives of pathology & laboratory medicine. 2023 Review GET IT
Locus specific human endogenous retroviruses reveal new lymphoma subtypes. bioRxiv : the preprint server for biology. 2023 Article GET IT
Times cited: 3855
Primary Effusion Lymphoma in an HIV-Negative Patient with Chronic Myeloid Leukemia Treated with Dasatinib. 2023 GET IT
EBV-positive PCNSL in older patients: incidence, characteristics, tumor pathology, and outcomes across a large multicenter cohort. Leukemia & lymphoma. 2023 Academic Article GET IT
Primary Mediastinal B-Cell Lymphoma in Children and Young Adults. Journal of the National Comprehensive Cancer Network : JNCCN. 2023 Review GET IT
Genetic subgroups inform on pathobiology in adult and pediatric Burkitt lymphoma. Blood. 2023 Academic Article GET IT
Times cited: 7
Cooperative super-enhancer inactivation caused by heterozygous loss of CREBBP and KMT2D skews B cell fate decisions and yields T cell-depleted lymphomas. bioRxiv : the preprint server for biology. 2023 Article GET IT
BTG1 mutation yields supercompetitive B cells primed for malignant transformation. Science (New York, N.Y.). 2023 Academic Article GET IT
Distinct Laboratory Test Result Profiles Between SARS-CoV-2 and Seasonable Influenza Infected Patients. Annals of clinical and laboratory science. 2022 Academic Article GET IT
SETD2 Haploinsufficiency Enhances Germinal Center-Associated AICDA Somatic Hypermutation to Drive B-cell Lymphomagenesis. Cancer discovery. 2022 Academic Article GET IT
Times cited: 4
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms. Leukemia. 2022 Review GET IT
Times cited: 349
C5b-9 and MASP2 deposition in skin and bone marrow microvasculature characterize hematopoietic stem cell transplant-associated thrombotic microangiopathy. Bone marrow transplantation. 2022 Letter GET IT
Times cited: 3
KSHV/HHV8-mediated hematologic diseases. Blood. 2022 Review GET IT
Times cited: 18
Metagenomic analysis to identify novel infectious agents in systemic anaplastic large cell lymphoma. Infectious agents and cancer. 2021 Academic Article GET IT
Times cited: 18
Rapid, robust, and sustainable antibody responses to mRNA COVID-19 vaccine in convalescent COVID-19 individuals. JCI insight. 2021 Academic Article GET IT
Times cited: 10
Genetic profiling and biomarkers in peripheral T-cell lymphomas: current role in the diagnostic work-up. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 2021 Review GET IT
Times cited: 10
TOP-Plus Is a Versatile Biosensor Platform for Monitoring SARS-CoV-2 Antibody Durability. Clinical chemistry. 2021 Academic Article GET IT
Times cited: 9
Comparison of Multiple Clinical Testing Modalities for Assessment of NPM1-Mutant AML. Frontiers in oncology. 2021 Academic Article GET IT
Times cited: 103
Mast cell sarcoma transdifferentiated from clonally-related T-lymphoblastic leukemia upon acquisition of TP53 mutation and genetic complexity. Leukemia & lymphoma. 2021 Letter GET IT
Times cited: 2
ROR1 targeting with the antibody-drug conjugate VLS-101 is effective in Richter syndrome patient-derived xenograft mouse models. Blood. 2021 Academic Article GET IT
Times cited: 37
Synergistic efficacy of the dual PI3K-δ/γ inhibitor duvelisib with the Bcl-2 inhibitor venetoclax in Richter syndrome PDX models. Blood. 2021 Academic Article GET IT
Times cited: 15
Machine Learning Highlights Downtrending of COVID-19 Patients with a Distinct Laboratory Profile. Health data science. 2021 Academic Article GET IT
Times cited: 147
Postconvalescent SARS-CoV-2 IgG and Neutralizing Antibodies are Elevated in Individuals with Poor Metabolic Health. The Journal of clinical endocrinology and metabolism. 2021 Academic Article GET IT
Times cited: 16
Association of Age With SARS-CoV-2 Antibody Response. JAMA network open. 2021 Academic Article GET IT
Times cited: 98
Biomarkers for Risk Stratification in Patients With Previously Untreated Follicular Lymphoma Receiving Anti-CD20-based Biological Therapy. The American journal of surgical pathology. 2021 Academic Article GET IT
Times cited: 8
Response-adapted therapy with infusional EPOCH chemotherapy plus rituximab in HIV-associated, B-cell non-Hodgkin's lymphoma. Haematologica. 2021 Academic Article GET IT
Times cited: 6
TOP-Plus is a Versatile Biosensor Platform for Monitoring SARS-CoV-2 Antibody Durability. medRxiv : the preprint server for health sciences. 2021 Article GET IT
Testing-on-a-probe biosensors reveal association of early SARS-CoV-2 total antibodies and surrogate neutralizing antibodies with mortality in COVID-19 patients. Biosensors & bioelectronics. 2021 Academic Article GET IT
Times cited: 14
ACCELERATE: A Patient-Powered Natural History Study Design Enabling Clinical and Therapeutic Discoveries in a Rare Disorder. Cell reports. Medicine. 2020 Academic Article GET IT
Times cited: 16
International evidence-based consensus diagnostic and treatment guidelines for unicentric Castleman disease. Blood advances. 2020 Academic Article GET IT
Times cited: 51
Targeted reduction of cholesterol uptake in cholesterol-addicted lymphoma cells blocks turnover of oxidized lipids to cause ferroptosis. The Journal of biological chemistry. 2020 Academic Article GET IT
Times cited: 17
Testing-on-a-probe biosensors reveal association of early SARS-CoV-2 total antibodies and surrogate neutralizing antibodies with mortality in COVID-19 patients. medRxiv : the preprint server for health sciences. 2020 Article GET IT
Routine Laboratory Blood Tests Predict SARS-CoV-2 Infection Using Machine Learning. Clinical chemistry. 2020 Academic Article GET IT
Times cited: 62
COVID-19 Viral and Serology Testing in New York City Health Care Workers. American journal of clinical pathology. 2020 Academic Article GET IT
Times cited: 10
Insufficient evidence exists to use histopathologic subtype to guide treatment of idiopathic multicentric Castleman disease. American journal of hematology. 2020 Academic Article GET IT
Times cited: 19
Autopsy Findings in 32 Patients with COVID-19: A Single-Institution Experience. Pathobiology : journal of immunopathology, molecular and cellular biology. 2020 Academic Article GET IT
Times cited: 74
American Registry of Pathology Expert Opinions: Recommendations for the diagnostic workup of mature T cell neoplasms. 2020 GET IT
Times cited: 6
Impact of Myc in HIV-associated non-Hodgkin lymphomas treated with EPOCH and outcomes with vorinostat (AMC-075 trial). Blood. 2020 Academic Article GET IT
Times cited: 27
TBL1XR1 Mutations Drive Extranodal Lymphoma by Inducing a Pro-tumorigenic Memory Fate. Cell. 2020 Academic Article GET IT
Times cited: 40
Challenges of HIV Lymphoma Clinical Trials in Africa: Lessons From the AIDS Malignancy Consortium 068 Study. JCO global oncology. 2020 Academic Article GET IT
Times cited: 2
Spleen: Development, anatomy and reactive lymphoid proliferations. Seminars in diagnostic pathology. 2020 Review GET IT
Times cited: 12
SARS-CoV-2 antibody characterization in emergency department, hospitalized and convalescent patients by two semi-quantitative immunoassays. Clinica chimica acta; international journal of clinical chemistry. 2020 Academic Article GET IT
Times cited: 28
Acute Myeloid Leukemia Presenting as Myeloid Sarcoma with a Predisposition to the Gynecologic Tract. 2019 GET IT
Times cited: 15
Synchronous multiple myeloma and Gaucher disease. 2019 GET IT
Times cited: 2
Peripheral eosinophilia in primary immunodeficiencies of actin dysregulation: A case series of Wiskott-Aldrich syndrome, CARMIL2 and DOCK8 deficiency and review of the literature. Annals of diagnostic pathology. 2019 Review GET IT
Times cited: 12
Chronic Myelogenous Leukemia Diagnosed in the Setting of Untreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma. 2019 GET IT
Virome capture sequencing does not identify active viral infection in unicentric and idiopathic multicentric Castleman disease. PloS one. 2019 Academic Article GET IT
Times cited: 17
Limited Tissue Samples: Hematopoietic Lesions - Three Case Examples of Judicious Use of Limited Material. Acta cytologica. 2019 Review GET IT
Times cited: 1
Dose-Adjusted EPOCH-R Compared With R-CHOP as Frontline Therapy for Diffuse Large B-Cell Lymphoma: Clinical Outcomes of the Phase III Intergroup Trial Alliance/CALGB 50303. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2019 Academic Article GET IT
Times cited: 208
Endobronchial Obstruction by a Solitary Extramedullary Plasmacytoma With Light-chain Amyloidosis. 2019 GET IT
International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease. Blood. 2018 Academic Article GET IT
Times cited: 166
Immunodeficiency-associated lymphoproliferative disorders: time for reappraisal?. Blood. 2018 Review GET IT
Times cited: 57
Novel Richter Syndrome Xenograft Models to Study Genetic Architecture, Biology, and Therapy Responses. Cancer research. 2018 Academic Article GET IT
Times cited: 28
KSHV induces immunoglobulin rearrangements in mature B lymphocytes. PLoS pathogens. 2018 Academic Article GET IT
Times cited: 26
Assessment of the Utility of Cytology and Flow Cytometry of Cerebrospinal Fluid Samples in Clinical Practice. Acta cytologica. 2018 Academic Article GET IT
Times cited: 6
Genetic and Functional Drivers of Diffuse Large B Cell Lymphoma. Cell. 2017 Academic Article GET IT
Times cited: 633
Inhibition of Hsp90 Suppresses PI3K/AKT/mTOR Signaling and Has Antitumor Activity in Burkitt Lymphoma. Molecular cancer therapeutics. 2017 Academic Article GET IT
Times cited: 47
The eIF4E inhibitor ribavirin as a potential antilymphoma therapeutic: early clinical data^. Leukemia & lymphoma. 2017 Letter GET IT
Times cited: 6
Resolution of a steroid-resistant, hypereosinophilic immune diathesis with mepolizumab and concomitant amelioration of a mixed thrombotic microangiopathy. 2017 GET IT
Times cited: 3
Enteropathy-associated T cell lymphoma subtypes are characterized by loss of function of SETD2. The Journal of experimental medicine. 2017 Academic Article GET IT
Times cited: 120
B-Cell and Classical Hodgkin Lymphomas Associated With Immunodeficiency: 2015 SH/EAHP Workshop Report-Part 2. American journal of clinical pathology. 2017 Academic Article GET IT
Times cited: 37
EBV-Positive B-Cell Proliferations of Varied Malignant Potential: 2015 SH/EAHP Workshop Report-Part 1. American journal of clinical pathology. 2017 Academic Article GET IT
Times cited: 62
HHV8/KSHV-Positive Lymphoproliferative Disorders and the Spectrum of Plasmablastic and Plasma Cell Neoplasms: 2015 SH/EAHP Workshop Report-Part 3. American journal of clinical pathology. 2017 Academic Article GET IT
Times cited: 58
Immunodeficiency and Dysregulation: Report of the 2015 Workshop of the Society for Hematopathology/European Association for Haematopathology. American journal of clinical pathology. 2017 Editorial Article GET IT
Times cited: 11
Primary/Congenital Immunodeficiency: 2015 SH/EAHP Workshop Report-Part 5. American journal of clinical pathology. 2017 Academic Article GET IT
Times cited: 13
T- and NK-Cell Lymphomas and Systemic Lymphoproliferative Disorders and the Immunodeficiency Setting: 2015 SH/EAHP Workshop Report-Part 4. American journal of clinical pathology. 2017 Academic Article GET IT
Times cited: 20
The Genetic Basis of Hepatosplenic T-cell Lymphoma. Cancer discovery. 2017 Academic Article GET IT
Times cited: 134
International, evidence-based consensus diagnostic criteria for HHV-8-negative/idiopathic multicentric Castleman disease. Blood. 2017 Academic Article GET IT
Times cited: 293
Corrigendum: Human immunodeficiency virus 1 Nef suppresses CD40-dependent immunoglobulin class switching in bystander B cells. Nature immunology. 2016 Academic Article GET IT
Plasmablastic lymphoma is treatable in the HAART era. A 10 year retrospective by the AIDS Malignancy Consortium. Leukemia & lymphoma. 2015 Letter GET IT
Times cited: 21
Hepatosplenic T-Cell Lymphoma Mimicking Acute Myeloid Leukemia. 2015 GET IT
Times cited: 6
Transfusion medicine illustrated. Hemoglobin C after a red blood cell transfusion for sickle cell disease. 2015 GET IT
The tumor virus landscape of AIDS-related lymphomas. Blood. 2015 Academic Article GET IT
Times cited: 54
Flow sorting and exome sequencing reveal the oncogenome of primary Hodgkin and Reed-Sternberg cells. Blood. 2014 Academic Article GET IT
Times cited: 237
Pancreatitis in patients treated with brentuximab vedotin: a previously unrecognized serious adverse event. Blood. 2014 Letter GET IT
Times cited: 48
Genetics of follicular lymphoma transformation. Cell reports. 2014 Academic Article GET IT
Times cited: 400
Bone marrow involvement by subcutaneous panniculitis-like T-cell lymphoma: a report of three cases. 2013 GET IT
Times cited: 15
Mechanism-based epigenetic chemosensitization therapy of diffuse large B-cell lymphoma. Cancer discovery. 2013 Academic Article GET IT
Times cited: 149
Immunodeficiency-associated lymphoid proliferations (ALPS, HIV, and KSHV/HHV8). Seminars in diagnostic pathology. 2013 Review GET IT
Times cited: 10
Lymphoid proliferations associated with human immunodeficiency virus infection. Archives of pathology & laboratory medicine. 2013 Review GET IT
Times cited: 40
Nuclear protein dysregulation in lymphoplasmacytic lymphoma/waldenstrom macroglobulinemia. American journal of clinical pathology. 2013 Academic Article GET IT
Times cited: 17
Genetic heterogeneity of diffuse large B-cell lymphoma. Proceedings of the National Academy of Sciences of the United States of America. 2013 Academic Article GET IT
Times cited: 424
Molecular and immunohistochemical detection of Kaposi sarcoma herpesvirus/human herpesvirus-8. Methods in molecular biology (Clifton, N.J.). 2013 Academic Article GET IT
Times cited: 6
The genetic landscape of mutations in Burkitt lymphoma. Nature genetics. 2012 Academic Article GET IT
Times cited: 441
13th International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies (ICMAOI) Bethesda, MD, USA. 7-8 November 2011. Abstracts. Infectious agents and cancer. 2012 Academic Article GET IT
A Cancer and Leukemia Group B multi-center study of DA-EPOCH-rituximab in untreated diffuse large B-cell lymphoma with analysis of outcome by molecular subtype. Haematologica. 2011 Academic Article GET IT
Times cited: 147
Clinical, morphologic, immunophenotypic, and molecular cytogenetic assessment of CD4-/CD8-γδ T-cell large granular lymphocytic leukemia. American journal of clinical pathology. 2011 Academic Article GET IT
Times cited: 39
Analysis of the coding genome of diffuse large B-cell lymphoma. Nature genetics. 2011 Academic Article GET IT
Times cited: 798
A20 (TNFAIP3) genetic alterations in EBV-associated AIDS-related lymphoma. Blood. 2011 Academic Article GET IT
Times cited: 28
Inactivating mutations of acetyltransferase genes in B-cell lymphoma. Nature. 2011 Academic Article GET IT
Times cited: 715
Normal bone marrow signal-transduction profiles: a requisite for enhanced detection of signaling dysregulations in AML. Blood. 2011 Academic Article GET IT
Times cited: 24
Bortezomib plus CHOP-rituximab for previously untreated diffuse large B-cell lymphoma and mantle cell lymphoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2010 Academic Article GET IT
Times cited: 278
BLIMP1 is a tumor suppressor gene frequently disrupted in activated B cell-like diffuse large B cell lymphoma. Cancer cell. 2010 Academic Article GET IT
Times cited: 233
Post-transplantation lymphoproliferative disorders: diagnosis, prognosis, and current approaches to therapy. Current oncology reports. 2010 Review GET IT
Times cited: 121
Primary effusion lymphoma: genomic profiling revealed amplification of SELPLG and CORO1C encoding for proteins important for cell migration. The Journal of pathology. 2010 Academic Article GET IT
Times cited: 51
Deep sequencing of the small RNA transcriptome of normal and malignant human B cells identifies hundreds of novel microRNAs. Blood. 2010 Academic Article GET IT
Times cited: 178
Epigenetic down-regulation of the tumor suppressor gene PRDM1/Blimp-1 in diffuse large B cell lymphomas: a potential role of the microRNA let-7. The American journal of pathology. 2010 Academic Article GET IT
Times cited: 51
Response to second-line therapy defines the potential for cure in patients with recurrent diffuse large B-cell lymphoma: implications for the development of novel therapeutic strategies. Clinical lymphoma, myeloma & leukemia. 2010 Academic Article GET IT
Times cited: 45
NK/T cell non-Hodgkin lymphoma in a HIV-positive patient. Journal of hematopathology. 2010 Academic Article GET IT
Times cited: 112
Expression of cancer testis antigen CT45 in classical Hodgkin lymphoma and other B-cell lymphomas. Proceedings of the National Academy of Sciences of the United States of America. 2010 Academic Article GET IT
Times cited: 33
Multicenter analysis of 80 solid organ transplantation recipients with post-transplantation lymphoproliferative disease: outcomes and prognostic factors in the modern era. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2010 Academic Article GET IT
Times cited: 246
Rituximab plus concurrent infusional EPOCH chemotherapy is highly effective in HIV-associated B-cell non-Hodgkin lymphoma. Blood. 2009 Academic Article GET IT
Times cited: 199
The mechanisms underlying MMR deficiency in immunodeficiency-related non-Hodgkin lymphomas are different from those in other sporadic microsatellite instable neoplasms. International journal of cancer. 2009 Academic Article GET IT
Times cited: 14
Targeted disruption of the S1P2 sphingosine 1-phosphate receptor gene leads to diffuse large B-cell lymphoma formation. Cancer research. 2009 Academic Article GET IT
Times cited: 107
Immunophenotypic analysis of AIDS-related diffuse large B-cell lymphoma and clinical implications in patients from AIDS Malignancies Consortium clinical trials 010 and 034. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2009 Academic Article GET IT
Times cited: 77
HIV-1 evades virus-specific IgG2 and IgA responses by targeting systemic and intestinal B cells via long-range intercellular conduits. Nature immunology. 2009 Academic Article GET IT
Times cited: 229
Diffuse blastoid B-cell lymphoma: a histologically aggressive variant of t(14;18)-negative follicular lymphoma. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 2009 Academic Article GET IT
Times cited: 14
BCL6 suppression of BCL2 via Miz1 and its disruption in diffuse large B cell lymphoma. Proceedings of the National Academy of Sciences of the United States of America. 2009 Academic Article GET IT
Times cited: 154
Priming of protective T cell responses against virus-induced tumors in mice with human immune system components. The Journal of experimental medicine. 2009 Academic Article GET IT
Times cited: 235
Mutations of multiple genes cause deregulation of NF-kappaB in diffuse large B-cell lymphoma. Nature. 2009 Academic Article GET IT
Times cited: 859
The stromal composition of mast cell aggregates in systemic mastocytosis. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 2009 Academic Article GET IT
Times cited: 10
Lymphoma diagnosis and plasma Epstein-Barr virus load during vicriviroc therapy: results of the AIDS Clinical Trials Group A5211. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2009 Academic Article GET IT
Times cited: 17
Role of defective Oct-2 and OCA-B expression in immunoglobulin production and Kaposi's sarcoma-associated herpesvirus lytic reactivation in primary effusion lymphoma. Journal of virology. 2009 Academic Article GET IT
Times cited: 11
Outcome of deferred initial therapy in mantle-cell lymphoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2009 Academic Article GET IT
Times cited: 286
Patients with Epstein Barr virus-positive lymphomas have decreased CD4(+) T-cell responses to the viral nuclear antigen 1. International journal of cancer. 2008 Academic Article GET IT
Times cited: 30
Expression of the follicular lymphoma variant translocation 1 gene in diffuse large B-cell lymphoma correlates with subtype and clinical outcome. American journal of clinical pathology. 2008 Academic Article GET IT
Times cited: 5
Immunophenotypic analysis of the Kaposi sarcoma herpesvirus (KSHV; HHV-8)-infected B cells in HIV+ multicentric Castleman disease (MCD). Histopathology. 2008 Academic Article GET IT
Times cited: 65
A peptomimetic inhibitor of BCL6 with potent antilymphoma effects in vitro and in vivo. Blood. 2008 Academic Article GET IT
Times cited: 145
Tyrosine kinase inhibition in diffuse large B-cell lymphoma: molecular basis for antitumor activity and drug resistance of dasatinib. Leukemia. 2008 Academic Article GET IT
Times cited: 53
MicroRNA-mediated down-regulation of PRDM1/Blimp-1 in Hodgkin/Reed-Sternberg cells: a potential pathogenetic lesion in Hodgkin lymphomas. The American journal of pathology. 2008 Academic Article GET IT
Times cited: 141
CD133 expression is not restricted to stem cells, and both CD133+ and CD133- metastatic colon cancer cells initiate tumors. The Journal of clinical investigation. 2008 Academic Article GET IT
Times cited: 793
Decreased differentiation of erythroid cells exacerbates ineffective erythropoiesis in beta-thalassemia. Blood. 2008 Academic Article GET IT
Times cited: 134
FDG-PET in prediction of splenectomy findings in patients with known or suspected lymphoma. Leukemia & lymphoma. 2008 Academic Article GET IT
Times cited: 15
Intensive treatment strategies may not provide superior outcomes in mantle cell lymphoma: overall survival exceeding 7 years with standard therapies. Annals of oncology : official journal of the European Society for Medical Oncology. 2008 Academic Article GET IT
Times cited: 66
Improving outcomes for patients with Burkitt lymphoma and HIV. AIDS patient care and STDs. 2008 Review GET IT
Times cited: 19
Phase 1/2 trial of BMS-275291 in patients with human immunodeficiency virus-related Kaposi sarcoma: a multicenter trial of the AIDS Malignancy Consortium. Cancer. 2008 Academic Article GET IT
Times cited: 11
KSHV LANA inhibits TGF-beta signaling through epigenetic silencing of the TGF-beta type II receptor. Blood. 2008 Academic Article GET IT
Times cited: 96
Evaluation of JAK2 in B and T cell neoplasms: identification of JAK2(V617F) mutation of undetermined significance (JMUS) in the bone marrow of three individuals. 2007 GET IT
Times cited: 18
Intestinal bacteria trigger T cell-independent immunoglobulin A(2) class switching by inducing epithelial-cell secretion of the cytokine APRIL. Immunity. 2007 Academic Article GET IT
Times cited: 592
Lack of A563G (I188V) missense mutation in RIZ/ PRDM2 in human diffuse large B-cell lymphomas. Genes, chromosomes & cancer. 2007 Letter GET IT
Times cited: 6
Ineffective erythropoiesis in beta-thalassemia is characterized by increased iron absorption mediated by down-regulation of hepcidin and up-regulation of ferroportin. Blood. 2007 Academic Article GET IT
Times cited: 247
Activation of peroxisome proliferator-activated receptor gamma contributes to the survival of T lymphoma cells by affecting cellular metabolism. The American journal of pathology. 2007 Academic Article GET IT
Times cited: 25
Dose-attenuated radioimmunotherapy with tositumomab and iodine 131 tositumomab in patients with recurrent non-Hodgkin's lymphoma (NHL) and extensive bone marrow involvement. Leukemia & lymphoma. 2007 Academic Article GET IT
Times cited: 11
Epithelial cells trigger frontline immunoglobulin class switching through a pathway regulated by the inhibitor SLPI. Nature immunology. 2007 Academic Article GET IT
Times cited: 244
Kaposi sarcoma-associated herpesvirus in non-Hodgkin lymphoma and reactive lymphadenopathy in Uganda. 2006 GET IT
Times cited: 15
Magnitude of stromal hemangiogenesis correlates with histologic subtype of non-Hodgkin's lymphoma. Clinical cancer research : an official journal of the American Association for Cancer Research. 2006 Academic Article GET IT
Times cited: 68
Hodgkin lymphoma cells express TACI and BCMA receptors and generate survival and proliferation signals in response to BAFF and APRIL. Blood. 2006 Academic Article GET IT
Times cited: 166
Case report: lymphoma arising in an ileal pouch anal anastomosis after immunomodulatory therapy for inflammatory bowel disease. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 2006 Comment GET IT
Times cited: 35
Splenic cord capillary hemangioma and anemia: resolution after splenectomy. 2006 GET IT
Times cited: 9
HIV-1 envelope triggers polyclonal Ig class switch recombination through a CD40-independent mechanism involving BAFF and C-type lectin receptors. Journal of immunology (Baltimore, Md. : 1950). 2006 Academic Article GET IT
Times cited: 182
Human immunodeficiency virus 1 Nef suppresses CD40-dependent immunoglobulin class switching in bystander B cells. Nature immunology. 2006 Academic Article GET IT
Times cited: 190
Mutational analysis of PRDM1 indicates a tumor-suppressor role in diffuse large B-cell lymphomas. Blood. 2006 Academic Article GET IT
Times cited: 199
Pathology of B-cell non-Hodgkin's lymphomas and multiple myeloma. Cancer treatment and research. 2006 Review GET IT
Times cited: 1
Intracranial nasal natural killer/T-cell lymphoma: immunopathologically-confirmed case and review of literature. Journal of neuro-oncology. 2005 Review GET IT
Times cited: 24
Abbreviated chemotherapy with fludarabine followed by tositumomab and iodine I 131 tositumomab for untreated follicular lymphoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2005 Academic Article GET IT
Times cited: 145
Combination antibody therapy with epratuzumab and rituximab in relapsed or refractory non-Hodgkin's lymphoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2005 Academic Article GET IT
Times cited: 167
Rituximab does not improve clinical outcome in a randomized phase 3 trial of CHOP with or without rituximab in patients with HIV-associated non-Hodgkin lymphoma: AIDS-Malignancies Consortium Trial 010. Blood. 2005 Academic Article GET IT
Times cited: 349
Accumulation of miR-155 and BIC RNA in human B cell lymphomas. Proceedings of the National Academy of Sciences of the United States of America. 2005 Academic Article GET IT
Times cited: 1208
Distinct subsets of primary effusion lymphoma can be identified based on their cellular gene expression profile and viral association. Journal of virology. 2005 Academic Article GET IT
Times cited: 110
KSHV-positive solid lymphomas represent an extra-cavitary variant of primary effusion lymphoma. The American journal of surgical pathology. 2004 Academic Article GET IT
Times cited: 256
Epratuzumab, a humanized anti-CD22 antibody, in aggressive non-Hodgkin's lymphoma: phase I/II clinical trial results. Clinical cancer research : an official journal of the American Association for Cancer Research. 2004 Academic Article GET IT
Times cited: 205
Lymphoma B cells evade apoptosis through the TNF family members BAFF/BLyS and APRIL. Journal of immunology (Baltimore, Md. : 1950). 2004 Academic Article GET IT
Times cited: 248
CD44 loss in gastric stromal tumors as a prognostic marker. The American journal of surgical pathology. 2004 Academic Article GET IT
Times cited: 41
Virus dynamics and immune responses during treatment in patients coinfected with hepatitis C and HIV. Journal of acquired immune deficiency syndromes (1999). 2004 Academic Article GET IT
Times cited: 26
ETO protein of t(8;21) AML is a corepressor for Bcl-6 B-cell lymphoma oncoprotein. Blood. 2003 Academic Article GET IT
Times cited: 62
Eosinophilic variant of chronic myeloid leukemia with vascular complications. Leukemia & lymphoma. 2003 Review GET IT
Times cited: 24
The emergence of Ph-, trisomy -8+ cells in patients with chronic myeloid leukemia treated with imatinib mesylate. Experimental hematology. 2003 Academic Article GET IT
Times cited: 40
Phase I/II trial of epratuzumab (humanized anti-CD22 antibody) in indolent non-Hodgkin's lymphoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2003 Academic Article GET IT
Times cited: 237
Anaplastic large cell lymphoma arising in a silicone breast implant capsule: a case report and review of the literature. Archives of pathology & laboratory medicine. 2003 Review GET IT
Times cited: 91
Human immunodeficiency virus (HIV)-associated polymorphic lymphoproliferative disorders. The American journal of surgical pathology. 2003 Academic Article GET IT
Times cited: 52
Gene expression profile analysis of AIDS-related primary effusion lymphoma (PEL) suggests a plasmablastic derivation and identifies PEL-specific transcripts. Blood. 2003 Academic Article GET IT
Times cited: 225
Lymphoid malignancies: immunophenotypic analysis. Advances in clinical chemistry. 2003 Review GET IT
Times cited: 2
A novel murine model of Cooley anemia and its rescue by lentiviral-mediated human beta-globin gene transfer. Blood. 2002 Academic Article GET IT
Times cited: 197
DNA polymerase mu gene expression in B-cell non-Hodgkin's lymphomas: an analysis utilizing in situ hybridization. The American journal of pathology. 2002 Academic Article GET IT
Times cited: 9
Leptomeningeal involvement in a patient with splenic lymphoma with villous lymphocytes. Leukemia & lymphoma. 2002 Review GET IT
Times cited: 6
Germinal center B cells regulate their capability to present antigen by modulation of HLA-DO. The Journal of experimental medicine. 2002 Academic Article GET IT
Times cited: 79
Successful treatment of murine beta-thalassemia intermedia by transfer of the human beta-globin gene. Blood. 2002 Academic Article GET IT
Times cited: 153
Analysis of the human herpesvirus 8 (HHV-8) genome and HHV-8 vIL-6 expression in archival cases of castleman disease at low risk for HIV infection. American journal of clinical pathology. 2002 Academic Article GET IT
Times cited: 42
Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nature medicine. 2001 Academic Article GET IT
Times cited: 1652
An angiocentric orbital lesion with an immature natural killer cell immunophenotype. 2001 GET IT
Times cited: 3
BCL-6 protein is expressed in precursor T-cell lymphoblastic lymphoma and in prenatal and postnatal thymus. Blood. 2001 Academic Article GET IT
Times cited: 39
Novel association of haemophagocytic syndrome with Kaposi's sarcoma-associated herpesvirus-related primary effusion lymphoma. 2000 GET IT
Times cited: 39
Autocrine stimulation of VEGFR-2 activates human leukemic cell growth and migration. The Journal of clinical investigation. 2000 Academic Article GET IT
Times cited: 414
Telomerase activity in B-cell non-Hodgkin lymphoma. Cancer. 2000 Academic Article GET IT
Times cited: 29
Inhibition of intestinal tumors by curcumin is associated with changes in the intestinal immune cell profile. The Journal of surgical research. 2000 Academic Article GET IT
Times cited: 105
Proliferative response of mantle cell lymphoma cells stimulated by CD40 ligation and IL-4. Leukemia. 2000 Academic Article GET IT
Times cited: 44
The spleen: anatomy and anatomical function. Seminars in hematology. 2000 Review GET IT
Times cited: 74
Mediastinal large B-cell lymphoma vs classic Hodgkin lymphoma. American journal of clinical pathology. 1999 Editorial Article GET IT
Times cited: 10
An Unusual Sonographic Manifestation of Lymphoma of the Breast. The breast journal. 1999 Academic Article GET IT
Times cited: 1
Enhanced endothelial cell apoptosis in splenic tissues of patients with thrombotic thrombocytopenic purpura. Blood. 1999 Academic Article GET IT
Times cited: 66
Administration of an unconjugated bile acid increases duodenal tumors in a murine model of familial adenomatous polyposis. Carcinogenesis. 1999 Academic Article GET IT
Times cited: 77
HAART-associated lymphadenopathy. 1999 GET IT
Times cited: 2
Incidence and outcome of primary Epstein-Barr virus infection and lymphoproliferative disease in pediatric heart transplant recipients. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 1998 Academic Article GET IT
Times cited: 55
BCL-6 gene mutations in posttransplantation lymphoproliferative disorders predict response to therapy and clinical outcome. Blood. 1998 Academic Article GET IT
Times cited: 131
The morphologic and molecular genetic categories of posttransplantation lymphoproliferative disorders are clinically relevant. Cancer. 1998 Academic Article GET IT
Times cited: 112
The sulfide metabolite of sulindac prevents tumors and restores enterocyte apoptosis in a murine model of familial adenomatous polyposis. Carcinogenesis. 1998 Academic Article GET IT
Times cited: 131
Apc gene mutation is associated with a dominant-negative effect upon intestinal cell migration. Cancer research. 1997 Academic Article GET IT
Times cited: 129
Epstein-Barr virus latent membrane protein-1 oncogene deletion in post-transplantation lymphoproliferative disorders. The American journal of pathology. 1997 Academic Article GET IT
Times cited: 29
Kaposi's sarcoma-associated herpesvirus sequences in benign lymphoid proliferations not associated with human immunodeficiency virus. Cancer. 1997 Academic Article GET IT
Times cited: 75
Epstein-Barr virus latent gene expression in primary effusion lymphomas containing Kaposi's sarcoma-associated herpesvirus/human herpesvirus-8. Blood. 1997 Academic Article GET IT
Times cited: 181
Erdheim-Chester disease of the central nervous system. Report of two cases. Journal of neurosurgery. 1997 Review GET IT
Times cited: 55
Molecular pathology of posttransplantation lymphoproliferative disorders. Seminars in diagnostic pathology. 1997 Conference Paper GET IT
Times cited: 111
CD4+ T-cell induction of Fas-mediated apoptosis in Burkitt's lymphoma B cells. Blood. 1996 Academic Article GET IT
Times cited: 76
Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpes virus. Blood. 1996 Academic Article GET IT
Times cited: 962
Cyclooxygenase-2 overexpression and tumor formation are blocked by sulindac in a murine model of familial adenomatous polyposis. Cancer research. 1996 Academic Article GET IT
Times cited: 555
Molecular characterization of primary mediastinal B cell lymphoma. The American journal of pathology. 1996 Academic Article GET IT
Times cited: 74
HIV-related primary non-Hodgkin's lymphoma of the vulva. Gynecologic oncology. 1996 Review GET IT
Times cited: 19
Post-transplantation lymphoproliferative disorders arising in solid organ transplant recipients are usually of recipient origin. The American journal of pathology. 1995 Academic Article GET IT
Times cited: 72
De novo CD5-positive and Richter's syndrome-associated diffuse large B cell lymphomas are genotypically distinct. The American journal of pathology. 1995 Academic Article GET IT
Times cited: 98
Molecular genetic analysis demonstrates that multiple posttransplantation lymphoproliferative disorders occurring in one anatomic site in a single patient represent distinct primary lymphoid neoplasms. 1995 GET IT
Times cited: 38
Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of posttransplantation lymphoproliferative disorders. Blood. 1995 Academic Article GET IT
Times cited: 546
Alterations of the beta-adrenergic receptor system after thoracic and abdominal surgery. Anesthesia and analgesia. 1994 Academic Article GET IT
Times cited: 24
Paraffin-resistant antigens detectable by antibodies L26 and polyclonal CD3 predict the B- or T-cell lineage of 95% of diffuse aggressive non-Hodgkin's lymphomas. American journal of clinical pathology. 1994 Academic Article GET IT
Times cited: 25
Phenotypic and functional characterization of T-BAM (CD40 ligand)+ T-cell non-Hodgkin's lymphoma. Blood. 1994 Academic Article GET IT
Times cited: 13
Molecular characterization of CD30+ anaplastic large-cell lymphoma: high frequency of c-myc proto-oncogene activation. Blood. 1994 Academic Article GET IT
Times cited: 62
Transferrin receptor expression in testis cancer. Journal of the National Cancer Institute. 1994 Letter GET IT
Times cited: 1
Post-thymic T cell lymphomas frequently overexpress p53 protein but infrequently exhibit p53 gene mutations. The American journal of pathology. 1994 Academic Article GET IT
Times cited: 68
Mesenchymal chondrosarcoma of the orbit. Report of three new cases and review of the literature. Cancer. 1994 Review GET IT
Times cited: 43
CD30 (Ki-1) positive anaplastic large cell lymphomas in individuals infected with the human immunodeficiency virus. Cancer. 1993 Academic Article GET IT
Times cited: 130
Posttransplantation lymphoproliferative disorders treated with cyclophosphamide-doxorubicin-vincristine-prednisone chemotherapy. 1993 GET IT
Times cited: 73
Down-regulation and desensitization of the beta-adrenergic receptor system of human lymphocytes after cardiac surgery. Anesthesia and analgesia. 1993 Academic Article GET IT
Times cited: 28
High levels of p53 protein expression do not correlate with p53 gene mutations in anaplastic large cell lymphoma. The American journal of pathology. 1993 Academic Article GET IT
Times cited: 118
Management of lymphoproliferative disorders after cardiac transplantation. The Annals of thoracic surgery. 1993 Academic Article GET IT
Times cited: 61
Megakaryocytes in bronchial brush cytology. A case report. 1993 GET IT
Times cited: 6
Structural and functional analysis of oncogenes and tumor suppressor genes in adult T-cell leukemia/lymphoma shows frequent p53 mutations. Blood. 1992 Academic Article GET IT
Times cited: 114
Monoclonal antibody OPD4 detects neoplastic T cells but does not distinguish between CD4 and CD8 neoplastic T cells in paraffin tissue sections. Human pathology. 1992 Academic Article GET IT
Times cited: 9
The bcl-2 gene translocation is undetectable in Hodgkin's disease by Southern blot hybridization and polymerase chain reaction. The American journal of pathology. 1992 Academic Article GET IT
Times cited: 29
T-cell activation-associated antigen expression by neoplastic T-cells. Hematologic pathology. 1992 Academic Article GET IT
Times cited: 10
The kinetics and temporal expression of T-cell activation-associated antigens CD15 (LeuM1), CD30 (Ki-1), EMA, and CD11c (LeuM5) by benign activated T cells. Hematologic pathology. 1992 Academic Article GET IT
Times cited: 38
Detection and characterization of human T-cell lymphotropic virus type I (HTLV-I) associated T-cell neoplasms in an HTLV-I nonendemic region by polymerase chain reaction. Blood. 1991 Academic Article GET IT
Times cited: 27
Intracerebral Hodgkin's disease in a human immunodeficiency virus-seropositive patient. 1991 GET IT
Times cited: 27
Hairy cell leukemia-associated antigen LeuM5 (CD11c) is preferentially expressed by benign activated and neoplastic CD8 T cells. The American journal of pathology. 1990 Academic Article GET IT
Times cited: 8
Progressive lymph node histology and its prognostic value in patients with acquired immunodeficiency syndrome and AIDS-related complex. Human pathology. 1989 Academic Article GET IT
Times cited: 52
Lymph node biopsy in patients with human immunodeficiency virus infections. Archives of surgery (Chicago, Ill. : 1960). 1988 Academic Article GET IT
Times cited: 5

more ...

less ...

Research

Sort by

Co-investigator Network

Funding awarded

B cell determinants of EBV latency awarded by National Cancer Institute Co-Investigator 2022 - 2027
Regulatory Crosstalk Between Human Endogenous Retroviruses, HIV, and EBV, in Lymphoma awarded by National Cancer Institute Co-Investigator 2021 - 2026
(PQ 6) New Models of KSHV Oncogenesis and KS Immune Environment awarded by National Cancer Institute Co-Investigator 2020 - 2025
The AIDS Malignancy Consortium Grant (AMC) - Resource Lab awarded by National Cancer Institute Co-Investigator 2020 - 2023

more ...

less ...

Background

education and training

M.D., Stanford University School of Medicine 1983
B.S., Oregon State University 1979

Contact

full name

Amy Chadburn

primary email

achadbur@med.cornell.edu

webpage

Clinical Profile

VIVO Weill Cornell Medical College

Amy Chadburn Professor of Pathology and Laboratory Medicine

Publications

selected publications

Research

Funding awarded

Background

education and training

Contact

full name

primary email

webpage

Phone

Publications

selected publications

Research

Funding awarded

Background

education and training

Contact

full name

primary email

webpage